BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20146168)

  • 1. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.
    Trepp R; Stettler C; Diem P; Christ ER
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):596-601. PubMed ID: 20146168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
    Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities in growth hormone deficiency.
    Lanes R
    Pediatr Endocrinol Rev; 2004 Dec; 2(2):209-15. PubMed ID: 16429108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report.
    Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A
    Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement therapy and cardiovascular diseases.
    Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GH on human skeletal muscle lipid metabolism in GH deficiency.
    Trepp R; Flück M; Stettler C; Boesch C; Ith M; Kreis R; Hoppeler H; Howald H; Schmid JP; Diem P; Christ ER
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1127-34. PubMed ID: 18413676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency: relation to postprandial dyslipidemia.
    Lanes R; Paoli M; Carrillo E; Villaroel O; Palacios A
    J Pediatr; 2004 Nov; 145(5):657-61. PubMed ID: 15520769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic consequences of GH deficiency.
    Jørgensen JO; Vestergaard E; Gormsen L; Jessen N; Nørrelund H; Christiansen JS; Møller N
    J Endocrinol Invest; 2005; 28(5 Suppl):47-51. PubMed ID: 16114276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes.
    Høst C; Christiansen JJ; Christiansen JS; Jorgensen JO; Gravholt CH
    Growth Horm IGF Res; 2010 Feb; 20(1):26-30. PubMed ID: 19660970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
    Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.